Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v8-EN
Language English English
Date Updated 2023-01-31 2023-01-30
Drug Identification Number 02387433 02387433
Brand name YAZ PLUS YAZ PLUS
Common or Proper name Drospirenone/Ethinyl Estradiol/Levomefolate Calcium Drospirenone/Ethinyl Estradiol/Levomefolate Calcium
Company Name BAYER INC BAYER INC
Ingredients LEVOMEFOLATE CALCIUM LEVOMEFOLATE CALCIUM ETHINYL ESTRADIOL DROSPIRENONE LEVOMEFOLATE CALCIUM LEVOMEFOLATE CALCIUM ETHINYL ESTRADIOL DROSPIRENONE
Strength(s) 0.451MG 0.451MG 0.02MG 3.00MG 0.451MG 0.451MG 0.02MG 3.00MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 28's 28's
ATC code G03AA G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-11-14 2022-11-14
Actual start date 2022-11-21 2022-11-21
Estimated end date 2023-01-27 2023-01-27
Actual end date 2023-01-30 2023-01-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Supply delay Supply delay
Health Canada comments